107 related articles for article (PubMed ID: 14752063)
1. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
[TBL] [Abstract][Full Text] [Related]
3. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
[TBL] [Abstract][Full Text] [Related]
4. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
5. Effect of antigenic heterogeneity on the efficacy of enhanced delivery of antibody-targeted chemotherapy in a human lung cancer intracerebral xenograft model in rats.
Muldoon LL
Neurosurgery; 2003 Dec; 53(6):1406-12; discussion 1412-3. PubMed ID: 14633307
[TBL] [Abstract][Full Text] [Related]
6. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
7. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway.
Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Feb; 312(2):424-31. PubMed ID: 15496615
[TBL] [Abstract][Full Text] [Related]
8. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
[TBL] [Abstract][Full Text] [Related]
10. Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.
Doolittle ND; Muldoon LL; Brummett RE; Tyson RM; Lacy C; Bubalo JS; Kraemer DF; Heinrich MC; Henry JA; Neuwelt EA
Clin Cancer Res; 2001 Mar; 7(3):493-500. PubMed ID: 11297239
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma.
Wang Y; Jin XQ; Wang S; Wang Q; Luo Q; Luo XJ
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):545-51. PubMed ID: 17085340
[TBL] [Abstract][Full Text] [Related]
12. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
[TBL] [Abstract][Full Text] [Related]
13. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Neuwelt EA; Brummett RE; Remsen LG; Kroll RA; Pagel MA; McCormick CI; Guitjens S; Muldoon LL
Cancer Res; 1996 Feb; 56(4):706-9. PubMed ID: 8630999
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Paintlia MK; Paintlia AS; Barbosa E; Singh I; Singh AK
J Neurosci Res; 2004 Nov; 78(3):347-61. PubMed ID: 15389835
[TBL] [Abstract][Full Text] [Related]
15. Protective role of thiol chelators against dimethylmercury induced toxicity in male rats.
Joshi D; Mittal DK; Shrivastava S; Shukla S
Bull Environ Contam Toxicol; 2010 May; 84(5):613-7. PubMed ID: 20401649
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal assessment of regional directed delivery in a rodent malignant glioma model.
Kondo A; Goldman S; Lulla RR; Mania-Farnell B; Vanin EF; Sredni ST; Rajaram V; Soares MB; Tomita T
J Neurosurg Pediatr; 2009 Dec; 4(6):592-8. PubMed ID: 19951051
[TBL] [Abstract][Full Text] [Related]
17. Second-line treatment with carboplatin for recurrent or progressive oligodendroglial tumors after PCV (procarbazine, lomustine, and vincristine) chemotherapy: a phase II study.
Soffietti R; Nobile M; Rudà R; Borgognone M; Costanza A; Laguzzi E; Mutani R
Cancer; 2004 Feb; 100(4):807-13. PubMed ID: 14770438
[TBL] [Abstract][Full Text] [Related]
18. Impact of 30-day oral dosing with N-acetyl-L-cysteine on Sprague-Dawley rat physiology.
Arfsten D; Johnson E; Thitoff A; Jung A; Wilfong E; Lohrke S; Bausman T; Eggers J; Bobb A
Int J Toxicol; 2004; 23(4):239-47. PubMed ID: 15371168
[TBL] [Abstract][Full Text] [Related]
19. [New developments in chemotherapy for experimental brain metastasis].
Kobayashi T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):757-65. PubMed ID: 3157350
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-acetylcysteine on carboplatin-induced ototoxicity and nitric oxide levels in a rat model.
Okur E; Kilinc M; Yildirim I; Kilic MA; Tolun FI
Laryngoscope; 2007 Dec; 117(12):2183-6. PubMed ID: 17909450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]